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Abstract 
Background: Sexually transmitted infections (STIs) are a major public health problem, especially in developing coun-
tries. The complications of untreated STIs in the female genital tract and their role in adverse pregnancy and perinatal 
outcomes have been well documented. The prevalence of STIs in Kenya among women in the general population has 
not been extensively studied and there is a lack of guidelines for screening of non-pregnant women. Knowledge of 
the prevalence of curable STIs among this population can provide a basis for integrating STI screening in family plan-
ning clinics.
Methods: A cross-sectional study was conducted between May and September 2013 at the family planning (FP) 
clinic at Kenyatta National Hospital (KNH) in Nairobi, Kenya. A total of 261 participants aged 18–49 years were enrolled; 
with data from 249 participants being analysed. An interviewer-administered questionnaire was used to gather socio-
demographic data and assess for risk factors. Each participant was screened for Trichomonas vaginalis (TV) by wet 
mount microscopy; Neisseria gonorrhoeae (GC) by culture and Chlamydia trachomatis (CT) by PCR.
Results: The prevalence of CT was 13 % (33/249), TV 0.4 % (1/249) and GC 0 % (0/249). All the infected women 
reported having had only one sexual partner in the previous 1 year. The age group prevalence for CT was highest 
in the 25–29 years age group (21 %). The syndromic approach to the management of STIs showed a low specificity 
(vaginal discharge, 65.7 %; lower abdominal pain, 60.6 %) and positive predictive value (vaginal discharge, 14 %; lower 
abdominal pain, 11.5 %) for the two commonly used symptoms when compared to the gold standard of CT PCR.
Conclusion: A high prevalence of CT was identified among women attending the FP Clinic at KNH. The study rein-
forces the need to implement regular screening for STIs among FP clinic attendants. It also reveals the need to review 
the usage of the syndromic approach for the management of STIs.
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Background
According to the 2008 WHO prevalence estimates for 
sexually transmitted infections (STIs), women in the Afri-
can region had a higher prevalence than men for Neisse-
ria gonorrhoeae (GC), Chlamydia trachomatis (CT) and 
Trichomonas vaginalis (TV) at 2.3, 2.6 and 20.2 % respec-
tively [1]. Despite a majority of cases of these curable 
STIs being asymptomatic [2], untreated STIs have been 
linked with complications such as adverse pregnancy and 
perinatal outcomes [3]; chronic pelvic illnesses [4] and 
increased risk of HIV acquisition [5]. Screening for STIs 
among women is therefore an important way of identi-
fying asymptomatic infections before any complications 
can arise. Indeed, studies have shown that screening for 
STIs reduces their sequelae [6].
Most of the recent information about the prevalence 
of STIs among women in Kenya has been from studies 
done among high-risk individuals [7] and special catego-
ries like pregnant women [8]. There is however a gap in 
information about the prevalence of STIs among women 
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in the general population. This is largely because the sur-
veillance of STIs, although recommended [9], has not 
been well implemented; with the major focus in Kenya 
in the last 10–15 years being on HIV [10]. This is further 
complicated by the fact that no guidelines exist for the 
screening of non-pregnant women for curable STIs.
In Kenya, the syndromic approach to treatment of gen-
ital infections is still used in public health facilities. This 
approach has however been shown to have little effect on 
the prevalence of STIs that are mostly asymptomatic [11]. 
Further, studies have demonstrated the high proportion 
of infected individuals with no reported symptoms who 
would provide a reservoir for infection and reinfection of 
susceptible individuals [2].
This study was therefore undertaken to determine the 
prevalence and the risk factors for C. trachomatis, N. 
gonorrhoeae and T. vaginalis in women aged 18–49 years 
attending the Family Planning Clinic at Kenyatta National 
Hospital in Nairobi, Kenya.
Methods
We conducted a prospective cross-sectional study at 
Kenyatta National Hospital’s (KNH) family planning (FP) 
clinic in Nairobi, Kenya between May and September 
2013. The KNH FP clinic, which offers contraceptive ser-
vices, runs daily from Monday to Friday between 9 a.m. 
and 4 p.m. and has an average attendance of five clients 
per day. All women aged 18–49  years attending the FP 
clinic during the study period were invited to participate 
in the study. Recruitment was done throughout the day 
by either the principal investigator or study nurses who 
also obtained written informed consent. Recruitment 
continued until the desired sample size was achieved. 
Inclusion criteria were age 18–49  years and willingness 
to participate in the study. Exclusion criteria were women 
who declined to give informed consent, those who had 
been treated for STIs and/or had been on broad spec-
trum antimicrobial agents in the preceding 3 weeks.
After informed consent had been obtained, a study 
nurse administered a questionnaire covering demo-
graphic data, sexual and symptomatic history. Two 
endocervical samples were then collected from each par-
ticipant and transported to the Department of Medical 
Microbiology, University of Nairobi within 5  minutes. 
The following tests were carried out: saline wet mounts 
were examined at 40× power for the presence of motile 
trichomonads, culture for N. gonorrhoeae was carried out 
on modified Thayer–Martin media and PCR for C. tra-
chomatis (GenoQuick CT, Hain Lifescience, Nehren Ger-
many) according to the manufacturer’s instructions.
Data was entered into Microsoft Excel and analysed 
using SPSS version 17.0. Chi square and Fisher’s exact 
tests were used to determine univariate associations 
with prevalent C. trachomatis infection. A p value of 
<0.05 was considered to be statistically significant. This 
study was approved by the Kenyatta National Hospital/
University of Nairobi Ethical Review Committee (Ref: 
KNH-ERC/A/96).
Results
A total of 261 participants, attending routine family 
planning clinic, were recruited consecutively during the 
May to September 2013 study period. Data from 12 par-
ticipants was excluded from analysis: two had not been 
sexually active for more than 4 years (the two were pris-
oners preparing for release to their families), while 10 
were discovered to have used broad-spectrum antimicro-
bial agents within the previous 2 weeks prior to the study. 
Data from 249 participants was therefore analysed.
The median age of the participants was 37 years (range: 
20–49 years). Majority of the participants were married 
(85  %) and 73  % had a level of education of secondary 
school and above. The demographic characteristics of the 
participants are summarised in Table 1.
The median age of sexual debut was 20  years (range: 
5–33  years). A majority of the participants (91  %) had 
only 1 sexual partner in the preceding 1 year while 4 and 
0.4 % had 2 and 3 sexual partners respectively in the pre-
ceding 1 year. Fifteen percentage of participants reported 
condom use during their last sex act. Treatment for 
STIs in the previous 3 months was reported by 10 % of 
participants.
The prevalence of CT was 13 % (33/249) (95 % CI 9.5, 
17.9), and TV 0.4 % (1/249). A co-infection of CT and TV 
was found in 0.4  % (1/249) participant. No participants 
(0 %; 0/249) were found to have GC.
The frequency of CT was highest among women aged 
25–29  years and lowest among those 45–49  years as 
shown in Table 2.
A majority, 30/33 (88  %), of CT positive participants 
were married with all of them having had only one sex-
ual partner in the previous one year although on fur-
ther analysis of those currently married and those not 
currently married, no statistical significance was found 
(p = 0.59). The characteristics of CT positive participants 
are summarised in Table 2.
The most commonly reported symptoms among the CT 
infected participants were vaginal discharge (36  %) and 
lower abdominal pain (33  %). However, 21/33 (64  %) of 
those who tested positive for CT did not report any vaginal 
discharge and 22/33 (67 %) had no lower abdominal pain.
Using the CT PCR used in the current study as the gold 
standard, the sensitivity, specificity and positive predic-
tive values (PPV) for the different symptoms used in the 
syndromic management of STIs was calculated as shown 
in Table 3.
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All the infected participants were informed of their 
results and requested to come to the FP clinic where rel-
evant treatment was prescribed. They were also advised 
to disclose the results to their sexual partners. Thirty 
one out of the thirty three infected participants showed 
up at the clinic for treatment. Two participants showed 
up with their partners where free screening was offered 
to the partners by the Principal Investigator. One par-
ticipant had received syndromic management before the 
CT PCR results were released to her. One participant 
declined medication.
Discussion
The prevalence of C. trachomatis (13  %) found in this 
study is comparable with that which has been reported in 
previous published studies from Kenya involving women. 
A CT prevalence of 12 % was found among women using 
intrauterine contraceptive devices at the KNH FP clinic 
between 1984 and 1986 [12]; Kohli et  al. [13] found a 
prevalence of 6  % among women attending outpatient 
clinics in Nairobi; 4 % was found among HIV-1 infected 
pregnant women and 4  % among women attending an 
STD referral clinic [14, 15] respectively. This indicates 
that the prevalence of C. trachomatis is still significant 
in the female population and introduction of routine 
screening procedures at FP clinics would help in reduc-
ing the burden of the disease among women.
Table 1 Characteristics of the study participants
n %
Age group
 <25 13 5
 25–29 28 11
 30–34 56 23
 35–39 67 27
 40–44 48 19
 >45–49 37 15
Marital status
 Currently married 211 85
 Not currently married 38 15
Education
 Primary and below 67 27
 Above primary 182 73
Occupation
 Paid employment 83 33
 Self employed 127 51
 Unemployed 39 16
Coitarche
 ≤20 years 160 64
 >20 years 78 31
 Missing 11 5
Treated STIs in last 3 months
 No 224 90
 Yes 25 10
New sexual partner in the last 3 months
 No 240 96
 Yes 9 4
Number of sexual partners in last 1 year
 0 11 4
 1 226 91
 ≥2 12 5
Table 2 Characteristics of CT positive participants
Characteristics Chlamydia  
infections/n
Prevalence (%) P value
Age group
 <25 1/13 8
 25–29 6/28 21
 30–34 6/56 11
 35–39 10/67 15
 40–44 8/48 17
 45–49 2/37 5
Marital status
 Married 29/211 14 0.59
 Not married 4/38 11
Education level
 Primary and  
below
11/67 16 0.37
 Above primary 22/182 12
Occupation
 Paid employment 11/83 13 0.9
 Self employed 16/127 13
 Unemployed 6/39 15
Coitarche
 ≤20 years 21/160 13 0.95
 >20 years 10/78 13
Treated STIs
 No 32/224 14 0.22
 Yes 1/25 4
Table 3 Sensitivity, specificity and  positive predictive 
value (PPV) of symptoms using CT PCR as the standard
Sensitivity  (%) Specificity  (%) PPV  (%)
Vaginal discharge 36 66 14
Lower abdominal pain 33 61 12
Vaginal itch 24 76 13
Pain on micturition 3 83 5
Intermenstrual bleeding 3 88 4
Bleeding after sexual  
intercourse
12 93 21
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However, the prevalence of 0 and 0.4  % for N. gonor-
rhoeae and T. vaginalis respectively is lower than what 
has been previously published in studies in which simi-
lar laboratory procedures were used. Marx et  al. [14] 
found a TV prevalence of 16 % and a GC prevalence of 
2 % among HIV-1 infected pregnant women in Nairobi; 
Fonck et al. [15] found a high prevalence of 23 % for TV 
and 7 % for GC among women with complaints of vagi-
nal discharge attending an STD referral clinic in Nairobi 
while Daly et  al. [16] found a GC prevalence of 3.2  % 
and a TV prevalence of 5.2  % among women attending 
FP clinic in Nairobi. It was not clear why the prevalence 
of TV in this study was low as most studies have shown 
that a higher prevalence of TV is found in women above 
the age of 30 years, which was the age for a majority of 
participants in this study. The low GC and TV prevalence 
could be explained by the fact that molecular methods 
were used for the detection of CT while GC was detected 
by culture while TV was detected by wet mount whose 
sensitivity varies from 38 to 82 % [17, 18].
All the women that were diagnosed with CT and TV 
reported having had only one sexual partner in the pre-
ceding 1 year and only 1/33 (3 %) reported a new sexual 
partner in the 3  months prior to the study. These find-
ings therefore suggest that the women were likely to have 
been infected by their regular partner. It further stresses 
the importance of partner notification, testing and treat-
ment as well as addressing the significant impact of the 
transmission between partners and the importance of 
directing prevention campaigns towards reducing infec-
tion from regular sexual partners.
The high proportion of asymptomatic participants who 
tested positive for C. trachomatis (64 % for vaginal discharge 
and 67 % for lower abdominal pain) corroborates findings 
in other studies and further stresses the importance of the 
aetiologic approach as opposed to the syndromic approach 
of managing STIs. However, due to lack of adequate labora-
tory infrastructure in the country, the WHO recommended 
syndromic approach for the management of STIs is utilised 
[19]. The syndromic management approach is based on the 
identification of consistent groups of symptoms and eas-
ily recognised signs and syndromes and the provision of 
treatment that will deal with the majority of or the most 
serious organisms responsible for producing a syndrome 
[20]. In the current study, evaluation of the diagnosis accu-
racy of the most commonly used symptoms in the syndro-
mic approach using the CT PCR as the gold standard was 
done. The evaluation showed a sensitivity of 36 and 33 %, a 
specificity of 66 and 61 % and a positive predictive value of 
14 and 12 % for vaginal discharge and lower abdominal pain 
respectively which are the most commonly used symptoms 
in the syndromic approach of managing STIs. This is com-
parable with what has been found in other studies: Detels 
R [2] found that over 80  % of the participants, who were 
drawn from five countries, were asymptomatic and that the 
positive predictive value of urethral or vaginal discharge was 
58  %; Fonck et  al. [14] found that the algorithm in use in 
Kenya as national policy had a sensitivity of 42 % and a spec-
ificity of 63 % for the detection of GC or CT and thus failed 
to discriminate between infected and uninfected women. 
This complicates identification and treatment of infected 
individuals and it also provides a large pool of asympto-
matic transmitters since individuals who have no symptoms 
are unlikely to seek testing and treatment. The findings 
from this study therefore lead to the conclusion that the 
syndromic approach to the management of STIs leads to 
an underestimation of the proportion of infected individu-
als, as a large majority tend to be asymptomatic. The aetio-
logic approach to management for symptomatic patients is 
therefore recommended in addition to screening in order to 
detect asymptomatic individuals.
Only 13/249 (5.2  %) participants were aged between 
18 and 24 years. This could be explained by the fact the 
KNH FP clinic charges for its FP services which could 
put them out of reach for women in this age group as 
a majority of them may be unemployed and/or in col-
leges and universities. The study therefore could have 
missed an age group with a higher burden of infection 
or more risk factors for the acquisition of STIs. The use 
of an interviewer-administered questionnaire to gather 
sensitive information on sexual history could have led 
to underreporting of sexual risk behaviours. The find-
ings therefore cannot easily be generalized to women in 
Kenya who may have different sociodemographic charac-
teristics and risk factors. A study involving women in the 
adolescent age group is therefore recommended.
Conclusions
The prevalence of C. trachomatis is significantly high 
among women in the general population. There is need 
to implement routine screening tests for CT and other 
STIs in FP clinics to aid in identifying asymptomatic 
cases and treating them before any sequelae arise. This 
study provides further evidence of the need to implement 
aetiologic management of STIs and the significance of 
directing preventive messages to individuals with regu-
lar sexual partners. There is an urgent need for studies 
designed to investigate the prevalence and risk factors of 
STIs among women aged 18–24 years in Kenya.
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